Correlation Between PDS Biotechnology and Fielmann Aktiengesellscha

Can any of the company-specific risk be diversified away by investing in both PDS Biotechnology and Fielmann Aktiengesellscha at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PDS Biotechnology and Fielmann Aktiengesellscha into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between PDS Biotechnology Corp and Fielmann Aktiengesellschaft, you can compare the effects of market volatilities on PDS Biotechnology and Fielmann Aktiengesellscha and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PDS Biotechnology with a short position of Fielmann Aktiengesellscha. Check out your portfolio center. Please also check ongoing floating volatility patterns of PDS Biotechnology and Fielmann Aktiengesellscha.

Diversification Opportunities for PDS Biotechnology and Fielmann Aktiengesellscha

0.53

Correlation Coefficient

PDS Biotechnology  Fielmann Aktiengesellscha

Very weak diversification

The 3 months correlation between PDS and Fielmann is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding PDS Biotechnology Corp and Fielmann Aktiengesellschaft in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fielmann Aktiengesellscha and PDS Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PDS Biotechnology Corp are associated (or correlated) with Fielmann Aktiengesellscha. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fielmann Aktiengesellscha has no effect on the direction of PDS Biotechnology i.e., PDS Biotechnology and Fielmann Aktiengesellscha go up and down completely randomly.

Pair Corralation between PDS Biotechnology and Fielmann Aktiengesellscha

Assuming the 90 days horizon PDS Biotechnology Corp is expected to under-perform the Fielmann Aktiengesellscha. In addition to that, PDS Biotechnology is 4.64 times more volatile than Fielmann Aktiengesellschaft. It trades about -0.24 of its total potential returns per unit of risk. Fielmann Aktiengesellschaft is currently generating about 0.24 per unit of volatility. If you would invest  4,020  in Fielmann Aktiengesellschaft on October 8, 2024 and sell it today you would earn a total of  145.00  from holding Fielmann Aktiengesellschaft or generate 3.61% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

PDS Biotechnology Corp  vs.  Fielmann Aktiengesellschaft

PDS Biotechnology Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days PDS Biotechnology Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Fielmann Aktiengesellscha

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Fielmann Aktiengesellschaft has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's technical and fundamental indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Pair Trading with PDS Biotechnology and Fielmann Aktiengesellscha

The main advantage of trading using opposite PDS Biotechnology and Fielmann Aktiengesellscha positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PDS Biotechnology position performs unexpectedly, Fielmann Aktiengesellscha can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fielmann Aktiengesellscha will offset losses from the drop in Fielmann Aktiengesellscha's long position.

The idea behind PDS Biotechnology Corp and Fielmann Aktiengesellschaft pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.